Select Publications

Books

2009, Hepatitis C: An Expanding Perspective, Dore GJ; Dore G; Lloyd AROLA, (eds.), IP Communications, East Hawthorn

Book Chapters

Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2021, 'Drought and Q fever: The association between trends in the incidence of infection and rainfall in rural Australia', in The Encyclopedia of Bacteriology Research Developments, pp. 1975 - 1988

Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2018, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1083 - 1096, http://dx.doi.org/10.1007/978-1-4939-7101-5_179

Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2017, 'Drought and q fever: The association between trends in the incidence of infection and rainfall in rural australia', in The Principles and Practice of Q Fever: The One Health Paradigm, pp. 301 - 315

Lloyd A, 2017, 'Chronic Fatigue and Postinfective Fatigue Syndromes', in Clinical Virology, Fourth Edition, American Society for Microbiology, pp. 373 - 384, http://dx.doi.org/10.1128/9781555819439.ch18

Lloyd AR, 2016, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology, pp. 371 - 384, http://dx.doi.org/10.1128/9781555819439.ch18

Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2014, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1 - 15, http://dx.doi.org/10.1007/978-1-4614-9610-6_179-1

Oldmeadow M; Lloyd AROLA, 2009, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, edn. 2, IP Communications, East Hawthorn, Victoria, Australia

Dore GJ; Temple-Smith M; Lloyd AROLA, 2009, 'Future challenges for hepatitis C', in Dore G; Temple-Smith M; Lloyd A (ed.), Hepatitis C: An Expanding Perspective, edn. 1, IP Communications, East Hawthorn, pp. 433 - 452, http://www.ipcommunications.com.au/

Oldmeadow M; Lloyd AR, 2005, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, edn. 2, IP Communications, East Hawthorn, Victoria, Australia, pp. 195 - 204

Lloyd AR; Hickie IB; Petersen PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment', in Current Clinical Topics in Infectious Diseases, edn. Original, Blackwell Science Asia, Carlton, Victoria, pp. 138 - 159

Lloyd AR; Hickie IB; Peterson PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment.', in Current Clinical Topics in Infectious Diseases, edn. 19, Blackwell Science Asia, Carlton, Victoria, pp. 135 - 159

Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, edn. Original, Churchill Livingstone, New York, pp. 343 - 355

Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, edn. 4, Churchill Livingstone, New York, pp. 343 - 355, http://dx.doi.org/10.1080/13651500050517948

Lloyd AR; Wakefield D, 1997, 'Treatment of chronic fatigue syndrome', in Intravenous Immunoglobulins in Clinical Practice, edn. Original, Marcel Dekker, New York, pp. 267 - 274

DWYER JM; LLOYD AR; HICKIE IB; WAKEFIELD D; BOUGHTON CR, 1991, 'The response of patients with chronic fatigue syndrome to intravenously administered gammaglobulin', in Immunotherapy with Intravenous Immunoglobulins, Elsevier, pp. 377 - 386, http://dx.doi.org/10.1016/b978-0-12-370725-3.50039-7

Journal articles

Murphy CE; Walker AK; O’Donnell M; Galletly C; Lloyd AR; Liu D; Weickert CS; Weickert TW, 2022, 'Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases', Translational Psychiatry, vol. 12, http://dx.doi.org/10.1038/s41398-021-01764-2

Howe AYM; Rodrigo C; Cunningham EB; Douglas MW; Dietz J; Grebely J; Popping S; Sfalcin JA; Parczewski M; Sarrazin C; de Salazar A; Fuentes A; Sayan M; Quer J; Kjellin M; Kileng H; Mor O; Lennerstrand J; Fourati S; Di Maio VC; Chulanov V; Pawlotsky JM; Harrigan PR; Ceccherini-Silberstein F; Garcia F; Martinello M; Matthews G; Fernando FF; Esteban JI; Müllhaupt B; Wiesch JSZ; Buggisch P; Neumann-Haefelin C; Berg T; Berg CP; Schattenberg JM; Moreno C; Stauber R; Lloyd A; Dore G; Applegate T; Ignacio J; Garcia-Cehic D; Gregori J; Rodriguez-Frias F; Rando A; Gozlan Y; Angelico M; Andreoni M; Babudieri S; Bertoli A; Cento V; Coppola N; Craxì A; Paolucci S; Parruti G; Pasquazzi C; Perno CF; Teti E; Vironet C; Lannergård A; Duberg AS; Aleman S; Gutteberg T; Soulier A; Gourgeon A; Chevaliez S; Pol S; Carrat F; Salmon D; Kaiser R; Knopes E; Gomes P; de Kneght R; Rijnders B; Poljak M; Lunar M; Usubillaga R; Seguin_Devaux C; Tay E; Wilson C; Wang DS; George J; Kok J; Pérez AB; Chueca N; García-Deltoro M; Martínez-Sapiña AM; Lara-Pérez MM; García-Bujalance S; Aldámiz-Echevarría T; Vera-Méndez FJ; Pineda JA; Casado M; Pascasio JM; Salmerón J; Alados-Arboledas JC; Poyato A; Téllez F; Rivero-Juárez A, 2022, 'Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals', JHEP Reports, vol. 4, pp. 100462 - 100462, http://dx.doi.org/10.1016/j.jhepr.2022.100462

Riaz N; Leung P; Bull RA; Lloyd AR; Rodrigo C, 2022, 'Evolution of within-host variants of the hepatitis C virus', Infection, Genetics and Evolution, vol. 99, http://dx.doi.org/10.1016/j.meegid.2022.105242

Carson JM; Dore GJ; Lloyd AR; Grebely J; Byrne M; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Matthews GV; Hajarizadeh B; SToP-C study group , 2022, 'Hepatitis C virus reinfection following direct acting antiviral treatment in the prison setting: the SToP-C study.', Clin Infect Dis, http://dx.doi.org/10.1093/cid/ciac246

Verveen A; Müller F; Lloyd A; Moss-Morris R; Omland T; Penninx B; Raijmakers RPH; van der Schaaf M; Sandler CX; Stavem K; Wessely S; Wyller VBB; Nieuwkerk P; Knoop H, 2022, 'A research agenda for post-COVID-19 fatigue', Journal of Psychosomatic Research, vol. 154, http://dx.doi.org/10.1016/j.jpsychores.2022.110726

Ji E; Boerrigter D; Cai HQ; Lloyd D; Bruggemann J; O'Donnell M; Galletly C; Lloyd A; Liu D; Lenroot R; Weickert TW; Shannon Weickert C, 2022, 'Peripheral complement is increased in schizophrenia and inversely related to cortical thickness', Brain, Behavior, and Immunity, vol. 101, pp. 423 - 434, http://dx.doi.org/10.1016/j.bbi.2021.11.014

Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2022, 'Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses', Cell Reports, vol. 38, pp. 110345, http://dx.doi.org/10.1016/j.celrep.2022.110345

Mostafavi H; Tharmarajah K; Vider J; West NP; Freitas JR; Cameron B; Foster PS; Hueston LP; Lloyd AR; Mahalingam S; Zaid A, 2022, 'Interleukin-17 contributes to Ross River virus-induced arthritis and myositis', PLoS Pathogens, vol. 18, pp. e1010185, http://dx.doi.org/10.1371/journal.ppat.1010185

Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR, 2022, '“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison', International Journal of Drug Policy, vol. 99, pp. 103456, http://dx.doi.org/10.1016/j.drugpo.2021.103456

Riaz N; Leung P; Barton K; Smith MA; Carswell S; Bull R; Lloyd AR; Rodrigo C, 2021, 'Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants', BMC Genomics, vol. 22, pp. 148, http://dx.doi.org/10.1186/s12864-021-07460-1

Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, vol. 98, pp. 103379, http://dx.doi.org/10.1016/j.drugpo.2021.103379

Lim AG; Stone J; Hajarizadeh B; Byrne M; Chambers GM; Martin NK; Grebely J; Dore GJ; Lloyd AR; Vickerman P, 2021, 'Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in Prisons', Hepatology, vol. 74, pp. 2366 - 2379, http://dx.doi.org/10.1002/hep.32002

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, vol. 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477

Sandler CX; Wyller VBB; Moss-Morris R; Buchwald D; Crawley E; Hautvast J; Katz BZ; Knoop H; Little P; Taylor R; Wensaas KA; Lloyd AR, 2021, 'Long COVID and post-infective fatigue syndrome: A review', Open Forum Infectious Diseases, vol. 8, http://dx.doi.org/10.1093/ofid/ofab440

Li H; Cvejic E; Gu B; Vollmer-Conna U; Hickie I; Wakefield D; Davenport T; Wiley J; Lloyd AR, 2021, 'Regulation of the Acute Sickness Response by the P2RX7 Receptor', Journal of Infectious Diseases, vol. 224, pp. 914 - 920, http://dx.doi.org/10.1093/infdis/jiab027

Li SH; Lloyd AR; Graham BM, 2021, 'Subjective sleep quality and characteristics across the menstrual cycle in women with and without Generalized Anxiety Disorder', Journal of Psychosomatic Research, vol. 148, http://dx.doi.org/10.1016/j.jpsychores.2021.110570

Adhikari A; Eltahla A; Lloyd AR; Rodrigo C; Agapiou D; Bull RA; Tedla N, 2021, 'Optimisation and validation of a new method for antibody dependent cellular phagocytosis in hepatitis C virus infection', Journal of Immunological Methods, vol. 495, http://dx.doi.org/10.1016/j.jim.2021.113087

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Loveday S; Tamaddoni M; Obeid S; Estivill Mercade G; Martinez M; Donnelly R; Bowman J; Trevethan L; Lagios K; Murrell T; Bath N; Tawil V; Stevens A; Topp L; Churchill A; Pinnock K; Martin N; Drew S; Harrod M; Smith A; Williams R; Cooper B; Somes K; Burns C; Kaur A; Lobo C; Conroy K; McCredie L; Café C; Anlezark J; Rawlinson W; Yeang M; Wynn M; Willenborg C, 2021, 'Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study', The Lancet Gastroenterology and Hepatology, vol. 6, pp. 533 - 546, http://dx.doi.org/10.1016/S2468-1253(21)00077-7

Zhao Y; Cai C; Samir J; Palgen JL; Keoshkerian E; Li H; Bull RA; Luciani F; An H; Lloyd AR, 2021, 'Human CD8 T-stem cell memory subsets phenotypic and functional characterization are defined by expression of CD122 or CXCR3', European Journal of Immunology, vol. 51, pp. 1732 - 1747, http://dx.doi.org/10.1002/eji.202049057

Brasher NA; Adhikari A; Lloyd AR; Tedla N; Bull RA, 2021, 'Hepatitis c virus epitope immunodominance and b cell repertoire diversity', Viruses, vol. 13, pp. 983 - 983, http://dx.doi.org/10.3390/v13060983

Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR, 2021, 'Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework', The Lancet Gastroenterology and Hepatology, vol. 6, pp. 391 - 400, http://dx.doi.org/10.1016/S2468-1253(20)30365-4

Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, vol. 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277

Rance J; Lafferty L; Treloar C, 2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C)', Harm reduction journal, vol. 18, pp. 46, http://dx.doi.org/10.1186/s12954-021-00494-4

Abayasingam A; Balachandran H; Agapiou D; Hammoud M; Rodrigo C; Keoshkerian E; Li H; Brasher NA; Christ D; Rouet R; Burnet D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Stella AO; Fichter C; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Tea F; Pilli D; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2021, 'Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection', Cell Reports Medicine, vol. 2, pp. 100228, http://dx.doi.org/10.1016/j.xcrm.2021.100228

Valencia BM; Cvejic E; Vollmer-Conna U; Hickie IB; Wakefield D; Li H; Pedergnana V; Rodrigo C; Lloyd AR, 2021, 'The severity of the pathogen-induced acute sickness response is affected by polymorphisms in genes of the NLRP3 inflammasome pathway', Brain, Behavior, and Immunity, vol. 93, pp. 186 - 193, http://dx.doi.org/10.1016/j.bbi.2021.01.005

Kwon JA; Chambers GM; Luciani F; Zhang L; Kinathil S; Kim D; Thein HH; Botha W; Thompson S; Lloyd A; Yap L; Gray RT; Butler T, 2021, 'Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis', PLoS ONE, vol. 16, pp. e0245896, http://dx.doi.org/10.1371/journal.pone.0245896

Seddiki N; Zaunders J; Phetsouphanh C; Brezar V; Xu Y; McGuire HM; Bailey M; McBride K; Hey-Cunningham W; Munier CML; Cook L; Kent S; Lloyd A; Cameron B; De St Groth BF; Koelsch K; Danta M; Hocini H; Levy Y; Kelleher AD, 2021, 'CD73+ CD127high long-term memory CD4 T cells are highly proliferative in response to recall antigens and are early targets in hiv-1 infection', International Journal of Molecular Sciences, vol. 22, pp. 1 - 28, http://dx.doi.org/10.3390/ijms22020912

Miller K; Treloar C; Lloyd AR, 2021, 'People in prison who inject drugs: who is trusted when it comes to information about hepatitis C?', Addiction Research and Theory, vol. 29, pp. 247 - 254, http://dx.doi.org/10.1080/16066359.2021.1879058

Cameron B; Webber K; Li H; Bennett BK; Boyle F; de Souza P; Wilcken N; Lynch J; Friedlander M; Goldstein D; Lloyd AR, 2021, 'Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study.', Brain Behav Immun Health, vol. 10, pp. 100189, http://dx.doi.org/10.1016/j.bbih.2020.100189

Adikari TN; Riaz N; Sigera C; Leung P; Valencia BM; Barton K; Smith MA; Bull RA; Li H; Luciani F; Weeratunga P; Thein TL; Lim VWX; Leo YS; Rajapakse S; Fink K; Lloyd AR; Fernando D; Rodrigo C, 2020, 'Single molecule, near full-length genome sequencing of dengue virus', Scientific Reports, vol. 10, http://dx.doi.org/10.1038/s41598-020-75374-1

Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', PLoS ONE, vol. 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106

Mina M; Underwood A; Eltahla A; Wu BR; Walker MR; Bull RA; Lloyd AR, 2020, 'Anti-envelope antibody responses in highly exposed seronegative individuals may be associated with protection from HCV infection', Journal of Viral Hepatitis, vol. 27, pp. 1012 - 1021, http://dx.doi.org/10.1111/jvh.13339

Tran B; Vajdic CM; Webber K; Laaksonen MA; Stavrou EP; Tiller K; Suchy S; Bosco AM; Harris MF; Lloyd AR; Goldstein D, 2020, 'Self-reported health, lifestyle and social circumstances of Australian adult cancer survivors: A propensity score weighted cross-sectional study', Cancer Epidemiology, vol. 67, pp. 101773 - 101773, http://dx.doi.org/10.1016/j.canep.2020.101773

Douglas MW; Tay ESE; Wang DS; Ong ATL; Wilson C; Phu A; Kok J; Dwyer DE; Bull RA; Lloyd AR; Applegate TL; Dore GJ; Howe AY; Harrigan R; George J, 2020, 'Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance', Hepatology Communications, vol. 4, pp. 904 - 915, http://dx.doi.org/10.1002/hep4.1496


Back to profile page